| Phytochemical Name | Acteoside |
| PubChem CID | 5281800 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib; Temozolomide; Thymic stromal lymphopoietin |
| Source |
Warm
Magnolia officinalis;
Cold
Buddleja officinalis;
Rehmannia glutinosa
|
| Phytochemical Name | Acteoside |
| PubChem CID | 5281800 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib; Temozolomide; Thymic stromal lymphopoietin |
| Source |
Warm
Magnolia officinalis;
Cold
Buddleja officinalis;
Rehmannia glutinosa
|
| Phytochemical Name | Acteoside |
| PubChem CID | 5281800 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib; Temozolomide; Thymic stromal lymphopoietin |
| Source |
Warm
Magnolia officinalis;
Cold
Buddleja officinalis;
Rehmannia glutinosa
|
| Phytochemical Name | Acteoside |
| PubChem CID | 5281800 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Sorafenib; Temozolomide; Thymic stromal lymphopoietin |
| Source |
Warm
Magnolia officinalis;
Cold
Buddleja officinalis;
Rehmannia glutinosa
|
